Examining the Feasibility and Impact of a Clinic-based Food Farmacy and Digital Culinary Medicine Program Among Cancer Survivors Treated in a Safety Net Hospital

Not Applicable

Not yet recruiting

• Conditions: Cancer

• Registration Number: NCT06760754
• Lead Sponsor: M.D. Anderson Cancer Center

Brief Summary

The goal of this study is to develop and test the feasibility of a theory-driven digital culinary medicine program among food insecure cancer survivors referred from the University of Texas MD Anderson Cancer Center Oncology Clinic at LBJ to the LBJ Food Farmacy program.

Detailed Description

Primary Objective:

Determine the feasibility of study recruitment goal, intervention adherence rate, attrition rate, data completion rate, and program satisfaction rate.

Secondary Objective:

Assess the preliminary efficacy of the digital culinary medicine intervention to improve diet quality, food security, quality of life, and downstream biological indicators of cardiometabolic health from baseline to post-intervention, as well as from baseline to 6 month follow up, among food insecure cancer survivors.

Study Timeline

• Status Verified: 2024-12
• Study First Submitted: 2024-12-30
• Study First Submitted QC: 2024-12-30
• Study First Posted: 2025-01-07
• Last Update Submitted: 2025-01-13
• Last Update Posted: 2025-01-14
• Study Start: 2025-06-30
• Primary Completion: 2026-01-01
• Study Completion: 2028-01-01

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

• Cancer survivors treated at the MD Anderson Oncology Program at LBJ Hospital over 18 years of age.
• Screen positive for food insecurity using the 2 question clinic-screener (Hunger Vital Signs)
• Receive referral to the LBJ Food Farmacy.
• Are within the first 5 years off of acute cancer treatment.
• Self-report having internet access.
• Self-report as being able to speak and read English or Spanish.
• Willing to complete study assessments.

Exclusion Criteria

• Unwilling or unable to complete study assessments
• Anyone under 18 years of age
• Self-report to not speak or read English or Spanish

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Safety and Adverse Events (AEs)	Through study completion; an average of 1 year	Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0

Trial Locations

Locations (1)

The University of Texas M. D. Anderson Cancer Center; 🇺🇸 Houston, Texas, United States